Protein C deficiency (PCD) is an inherited condition characterized by a significant decrease or absence of functional activity of protein C in the blood serum, which leads to an increased susceptibility to venous thrombosis and thromboembolism. Protein C is an important coagulant protein that is involved in the process of hemostasis and has anticoagulant properties, and its deficiency leads to an imbalance in the blood coagulation system. It is important to note that protein C levels can sometimes be reduced as a result of acquired disorders such as inflammatory processes or liver disease, but the inherited forms of PCD have the most serious consequences and require a special careful approach to diagnosis and treatment.
History of the disease and interesting historical facts
Protein C deficiency was first described in 1979, when researchers found an association with increased thrombolytic activity in patients with thrombophilia. The gene responsible for protein C synthesis was originally isolated and is located on chromosome 2. In the 1980s, significant research was conducted to elucidate the molecular mechanisms of the disease, which led to further study of its genetic basis and the possibility of genetic testing. Research has shown that 1 in 2,000 healthy newborns may have a defect in the protein C gene, confirming its prevalence in the population.
Epidemiology
Protein C deficiency occurs in people of different races and ethnic groups, but there is a difference in its frequency depending on the region. According to epidemiological studies, the frequency of hereditary protein C deficiency in different populations varies from 1:200 to 1:5000 newborns. Statistics show that this disease is more common in people with a family history of thrombophilia. The frequency of venous thromboembolism among patients with DPS is significantly higher compared to the general population, which indicates a high clinical significance of this disease.
Genetic predisposition to this disease
Protein C deficiency is a hereditary disorder transmitted in an autosomal recessive manner. The main genes involved are located on chromosome 2 and encode the synthesis of protein C. The most common mutations that lead to the deficiency are:
- Mutations in the region encoding the active site of protein C;
- Deletions or nucleotide substitutions in the protein C gene;
- Polymorphisms affecting gene expression and function.
Detection of specific mutations makes it possible to identify genetic predisposition and assess the risk of developing the disease in other family members.
Risk factors for the development of this disease
Risk factors that contribute to the development of DPS can be divided into two main types: genetic and external.
Genetic risk factors:
- Family history of thrombophilia;
- The presence of other hereditary syndromes associated with coagulation disorders;
- Parallel genetic diseases affecting the hemostasis system.
External risk factors:
- Long-term immobilization (for example, after surgery or injury);
- Pregnancy and postpartum period;
- Surgical interventions;
- Some drugs that affect the hemostasis system.
Diagnosis of this disease
Several methods are used to diagnose protein C deficiency, including laboratory tests and clinical manifestations.
The main symptoms of DPS include:
- Recurrent venous thromboembolism;
- Deep vein thrombosis;
- Pulmonary embolism;
- Arterial thrombi in early childhood.
Laboratory tests:
- Determination of serum protein C level;
- Protein C activity tests;
- Thrombophilia tests, including measurements of other anticoagulant proteins.
Radiological examinations such as ultrasound can detect thrombi in veins. Differential diagnosis should include other conditions that can cause thrombus formation, such as anticardiolipin syndrome and prothrombin deficiency.
Treatment
Treatment of protein C deficiency may include both conservative and surgical methods. General treatment includes the following aspects:
- Prevention of thromboembolism, especially in patients at increased risk;
- Patient education on thrombosis prevention;
- Use of compression garments.
Pharmacological treatment:
- Anticoagulants (eg, warfarin) to prevent and treat blood clots;
- Preparations containing protein C, in case of its extremely low level.
Surgical treatment may be necessary to eliminate thrombus formation in the veins, especially if thrombophlebitis develops.
List of medications used to treat this disease
The main groups of drugs used to treat protein C deficiency include:
- Anticoagulants: warfarin, apixaban, rivaroxaban;
- Preparations containing recombinant protein C;
- Anti-inflammatory drugs to reduce inflammatory activity in blood vessels.
Disease monitoring
Monitoring of patients with protein C deficiency includes periodic testing of protein C levels, assessment of the timing of anticoagulant therapy, and monitoring of the patient's health status.
Control stages of monitoring:
- Regular examinations by a hematologist;
- Control assessment of anticoagulant therapy;
- Measurement of vitamin K levels as a component of anticoagulant therapy.
The prognosis of the disease largely depends on timely diagnosis and adequate treatment. Complications such as thromboembolism can lead to serious consequences for the patient's health.
Age-related features of the disease
Protein C deficiency can manifest itself at any age, but special features are observed in newborns and elderly patients. In newborns, the risk of thrombosis is significantly higher, since their hemostasis system is not yet fully developed. In the elderly, the presence of DPS in combination with other comorbid conditions increases the risk of thrombosis and complications such as strokes or heart attacks.
Questions and Answers
- What is Protein C Deficiency? This is an inherited condition in which there is decreased activity of protein C, which significantly increases the risk of blood clots.
- What are the main symptoms of DPS? Prominent symptoms include recurrent venous thromboembolism, pulmonary embolism, and arterial thromboembolism in young adults.
- How is protein C deficiency diagnosed? Diagnosis is made using laboratory tests to determine protein C levels and clinical tests for thrombus formation.
- How is protein C deficiency treated? Treatment includes anticoagulant therapy, preventive measures and, in some cases, surgery.
- Can blood clots be prevented with protein C deficiency? Yes, the risk of blood clots can be significantly reduced with anticoagulant therapy and lifestyle changes.
